Latest Postings:

Alternative View Points

Wargo KA. Clincial Judgment: To Renal Dose Adjust Antimicrobials or Not
commenting on Golik MV, Lawrence KR. Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft-Gault and Modification of Diet in Renal Disease. Pharmacotherapy 2008;28(9):1125-1132.

Hunt J. The Future of Advanced Pharmacy Practice: Wildcats versus Zeroes

ACCP Paper: Economic Evaluations of Clinical Pharmacy Services: 2001–2005 by Alexandra Perez, Pharm.D., Fred Doloresco, Pharm.D., M.S., James M. Hoffman, Pharm.D., M.S., Patrick D. Meek, Pharm.D., M.S., Daniel R. Touchette, Pharm.D., M.A., Lee C. Vermeulen, M.S., and Glen T. Schumock, Pharm.D., M.B.A.

ACCP Guideline: Guidelines for Pharmacoeconomic and Outcomes Research Fellowship Training Programs: Joint Guidelines from the American College of Clinical Pharmacy and the International Society of Pharmacoeconomics and Outcomes Research by Sandra Kane-Gill, Pharm.D., M.Sc., Prabashni Reddy, Pharm.D., M.Sc., Shiraz R. Gupta, Pharm.D., M.P.H., and Alan W. Bakst, Pharm.D., M.B.A.

ACCP White Paper: Essential Components of a Faculty Development Program for Pharmacy Practice Faculty by Eric G. Boyce, Pharm.D., Jill S. Burkiewicz, Pharm.D., Mark R. Haase, Pharm.D., Eric J. MacLaughlin, Pharm.D., Alissa R. Segal, Pharm.D., Eunice P. Chung, Pharm.D., Lingtak-Neander Chan, Pharm.D., Raylene M. Rospond, Pharm.D., Joseph A. Barone, Pharm.D., Stephen W. Durst, Pharm.D., and Barbara G. Wells, Pharm.D. Pharmacotherapy 2009:28(10):245e–268e.

ACCP White Paper: Ethical Issues Related to Clinical, Translational, and Health System Research by Michael E. Klepser, Pharm.D., FCCP, Gary R. Matzke, Pharm.D., FCCP, Eva Vivian, Pharm.D., Mark Granberry, Pharm.D., Thomas Majerus, Pharm.D., FCCP, Barbara Wiggins, Pharm.D., Christina Hill-Zabala, Pharm.D., Nicole Weimert, Pharm.D., and Marsha A. Raebel, Pharm.D., FCCP. Pharmacotherapy 2008;28(10):229e-243e.

ACCP White Paper: Quality Experiential Education by Krystal K. Haase, Pharm.D., FCCP, Maureen A. Smythe, Pharm.D., FCCP, Patricia L. Orlando, Pharm.D., FCCP, Beth H. Resman-Targoff, Pharm.D., FCCP, and Lisa S. Smith, Pharm.D. with contributions by: Sheryl J. Herner, Pharm.D., S. Dee Melnyk, Pharm.D., Nicole M. Paolini, Pharm.D., Kalen B. Porter, Pharm.D., Phillip T. Rodgers, Pharm.D., FCCP, and Avery L. Spunt, M.S. Pharmacotherapy 2008;28(10):219e-227e.

Ambrosini MT. Autoimmunity and Schizophrenia
commenting on Goldsmith CW, Rogers DP. The Case for Autoimmunity in the Etiology of Schizophrenia. Pharmacotherapy 2008;28(6):730-741.

Guidelines for Submitting Case Reports for Publication
These guidelines, published with the title "Guidelines for submitting adverse event reports for publication" in Pharmacoepidemiology and Drug Safety, 2007;16:581-587 will be helpful for all authors considering the submission of a case report to the journal.